T1	Sex 195 201	female
T2	Strain 202 216	Sprague-Dawley
T3	Species 217 221	rats
T4	Species 298 302	rats
T5	Endpoint 341 343	az
T6	Endpoint 347 356	acepromaz
T7	DoseRoute 390 400	lar inject
T8	TestArticle 581 589	estrogen
T9	GroupSize 607 612	three
T10	SampleSize 671 673	15
T11	Species 674 678	rats
T12	GroupSize 695 700	three
T13	Species 701 706	rats)
T14	DoseRoute 712 715	inj
T15	DoseRoute 717 729	ted subcutan
T16	DoseRoute 733 735	ly
T17	TestArticle 748 755	17  -E2
T18	Dose 757 759	60
T19	DoseUnits 760 765	 g/kg
T20	GroupSize 767 769	12
T21	Species 770 775	rats)
T22	Vehicle 783 793	sesame oil
T23	Dose 803 806	200
T24	DoseUnits 807 809	 L
T25	GroupSize 811 816	three
T26	Species 817 823	rats).
T27	TestArticle 839 848	estradiol
T28	GroupName 848 859	-treated an
T29	GroupName 861 864	als
T30	Dose 916 918	40
T31	Dose 920 923	120
T32	Dose 929 932	400
T33	DoseUnits 933 938	 g/kg
T34	TestArticle 943 946	BPA
T35	TestArticlePurity 948 953	> 99%
T36	SampleSize 1029 1031	12
T37	Species 1032 1036	rats
T38	DoseRoute 1042 1045	inj
T39	DoseRoute 1047 1059	ted subcutan
T40	DoseRoute 1063 1065	ly
T41	GroupSize 1067 1072	three
T42	Species 1073 1077	rats
T43	TestArticle 1098 1105	17  -E2
T44	Dose 1107 1109	45
T45	DoseUnits 1110 1115	 g/kg
T46	TestArticle 1118 1121	BPA
T47	Dose 1123 1126	300
T48	DoseUnits 1127 1132	 g/kg
T49	TestArticle 1152 1159	17  -E2
T50	Dose 1161 1163	45
T51	DoseUnits 1164 1169	 g/kg
T52	TestArticle 1176 1179	BPA
T53	Dose 1181 1184	300
T54	DoseUnits 1185 1190	 g/kg
T55	Vehicle 1200 1210	sesame oil
T56	Dose 1220 1223	200
T57	DoseUnits 1224 1226	 L
T58	TimeUnits 1245 1255	utes after
T59	DoseRoute 1256 1265	injection
T60	Vehicle 1360 1366	saline
T61	TestArticle 1834 1839	edded
T62	EndpointUnitOfMeasure 2071 2075	mber
T63	Endpoint 2076 2094	of pyramidal cells
T64	Endpoint 2119 2122	xam
T65	Endpoint 2266 2298	pyramidal cell density value (D)
T66	EndpointUnitOfMeasure 2317 2325	D = N/sT
T67	Endpoint 2697 2704	in PSSD
T68	Endpoint 2902 2904	rs
T69	EndpointUnitOfMeasure 2925 2930	Areas
T70	Endpoint 2931 2954	of CA1 stratum radiatum
T71	EndpointUnitOfMeasure 3061 3067	volume
T72	Endpoint 3068 3091	of CA1 stratum radiatum
T73	Species 3100 3103	rat
T74	Endpoint 4508 4518	apses were
T75	EndpointUnitOfMeasure 4519 4524	count
T76	Endpoint 4658 4662	spin
T77	Endpoint 4664 4666	sy
T78	Endpoint 4667 4677	apses were
T79	EndpointUnitOfMeasure 4678 4683	count
T80	EndpointUnitOfMeasure 5155 5162	density
T81	Endpoint 5163 5178	of spine synaps
T82	EndpointUnitOfMeasure 5242 5243	n
T83	EndpointUnitOfMeasure 5244 5248	mber
T84	Endpoint 5249 5260	of synapses
T85	Endpoint 5377 5382	ess t
T86	Endpoint 5532 5536	PSSD
T87	EndpointUnitOfMeasure 5571 5622	dividing Nv(syn) by the volume correction factor kv
T88	Endpoint 5625 5643	Rat uterine weight
T89	Endpoint 5662 5684	uterotrophic responses
T90	SampleSize 5706 5708	12
T91	Species 5709 5713	rats
T92	GroupSize 5730 5731	3
T93	TimeAtFirstDose 5745 5746	1
T94	TimeUnits 5747 5751	week
T95	TimeAtFirstDose 5752 5769	after ovariectomy
T96	DoseRoute 5775 5782	subcuta
T97	DoseRoute 5784 5798	ous injections
T98	TestArticle 5802 5809	17  -E2
T99	Dose 5811 5813	60
T100	DoseUnits 5814 5819	 g/kg
T101	TestArticle 5822 5825	BPA
T102	Dose 5827 5830	400
T103	DoseUnits 5831 5836	 g/kg
T104	TestArticle 5861 5864	BPA
T105	Dose 5866 5869	400
T106	DoseUnits 5870 5875	 g/kg
T107	TestArticle 5881 5888	17  -E2
T108	Dose 5890 5892	60
T109	DoseUnits 5893 5898	 g/kg
T110	DoseFrequency 5901 5906	daily
T111	DoseDuration 5911 5912	3
T112	DoseDurationUnits 5913 5917	days
T113	GroupName 5919 5929	Control an
T114	GroupName 5931 5934	als
T115	Vehicle 5948 5958	sesame oil
T116	Dose 5968 5971	200
T117	DoseUnits 5972 5978	 L/day
T118	TimeEndpointAssessed 5989 5990	x
T119	TimeUnits 5991 5996	hours
T120	TimeEndpointAssessed 5997 6011	after the last
T121	DoseRoute 6012 6021	injection
T122	Endpoint 6058 6111	uteri were dissected free of adhering fat and connect
T123	Endpoint 6113 6165	e tissue, drained of intraluminal fluid, and weighed
T124	GroupSize 6262 6267	three
T125	GroupName 6280 6295	treatment group
T126	GroupSize 6330 6335	three
T127	GroupName 6348 6363	treatment group
T128	EndpointUnitOfMeasure 6576 6579	cou
T129	Endpoint 6589 6595	synaps
T130	GroupSize 6685 6690	three
T131	Endpoint 6723 6727	PSSD
T132	Endpoint 6820 6824	PSSD
T133	Endpoint 6852 6855	ide
T134	GroupName 7181 7197	treatment groups
T135	GroupName 7209 7233	control versus treatment
T136	Endpoint 7347 7355	BPA dose
T137	Endpoint 7363 7369	e data
